Salt is essential for regulating important body functions, but too much can be harmful. Here are some strategies to reduce sodium in your diet. If you live with a chronic condition like diabetes, high ...

CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...

People with diabetes who are also a part of the LGBTQ community face unique challenges when it comes to healthcare, dealing with stigma and body image issues. Shawn Laib describes his personal ...

While continuous glucose monitors are part of routine care for people with type 1 diabetes, there are many other people who may also benefit from real-time insight into glucose levels. Experts ...

Nausea and stomach problems are well-known side effects of GLP-1s, but you may be less familiar with other pros and cons of these powerful medications. With more and more people using GLP-1 receptor ...

Why is this study important? This study is testing endoscopic intestinal re-cellularization (ReCET) therapy to see if it can help people with type 2 diabetes improve their blood sugar management. The ...

In the world of diabetes management, one size does not fit all. Doing Diabetes Your Way is an ongoing video series that offers accessible, relatable content that encourages individuals to manage ...

An AID system used by thousands in the U.K. and across Europe is shown to make diabetes care easier for young children and their parents, as well as pregnant women who require tight glucose ranges. An ...

Research finds that finerenone may offer benefits beyond treating chronic kidney disease in people with type 2 diabetes. A 2025 study found that finerenone also reduced the risk of developing type 2 ...

A recent study found that SGLT-2 inhibitors, which assist the kidneys in removing sugar from the body through urine, may provide protection against dementia and Parkinson’s disease.. Researchers from ...

While not completely shocked by his diagnosis with type 2 diabetes 17 years ago, broadcaster and former NFL player Mike Golic described the experience as a “slap of reality.” “I was in a profession ...

Clinical Trials Identifier: NCT06269107. Trial Name: A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels ...